Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 3
1989 1
1994 1
2001 1
2003 1
2016 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Paratesticular rhabdomyosarcoma: delayed effects of multimodality therapy and implications for current management.
Hughes LL, Baruzzi MJ, Ribeiro RC, Ayers GD, Rao B, Parham DM, Pratt CB, Kun LE. Hughes LL, et al. Cancer. 1994 Jan 15;73(2):476-82. doi: 10.1002/1097-0142(19940115)73:2<476::aid-cncr2820730237>3.0.co;2-n. Cancer. 1994. PMID: 8293416
BACKGROUND: The combined modalities of surgery, chemotherapy, and radiation therapy have greatly improved the survival rate in childhood paratesticular rhabdomyosarcoma, but the incidence of complications and late side effects is a cause for concern. METHODS: …
BACKGROUND: The combined modalities of surgery, chemotherapy, and radiation therapy have greatly improved the survival rate in childh …
Surgical management of paratesticular rhabdomyosarcoma: A consensus opinion from the Children's Oncology Group, European paediatric Soft tissue sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe.
Rogers TN, Seitz G, Fuchs J, Martelli H, Dasgupta R, Routh JC, Hawkins DS, Koscielniak E, Bisogno G, Rodeberg DA. Rogers TN, et al. Pediatr Blood Cancer. 2021 Apr;68(4):e28938. doi: 10.1002/pbc.28938. Epub 2021 Feb 1. Pediatr Blood Cancer. 2021. PMID: 33522706 Free PMC article.
The treatment of paratesticular rhabdomyosarcoma (PT-RMS) has varied over time and by cooperative group. ...The INSTRuCT surgical committee has been given charge of the development of internationally applicable consensus guidelines for the surgical treatment of r …
The treatment of paratesticular rhabdomyosarcoma (PT-RMS) has varied over time and by cooperative group. ...The INSTRuCT surgi …
Paraaortic lymphadenectomy is not necessary in the treatment of localized paratesticular rhabdomyosarcoma.
Olive D, Flamant F, Zucker JM, Voute P, Brunat-Mentigny M, Otten J, Dutou L. Olive D, et al. Cancer. 1984 Oct 1;54(7):1283-7. doi: 10.1002/1097-0142(19841001)54:7<1283::aid-cncr2820540709>3.0.co;2-j. Cancer. 1984. PMID: 6467153
Paraaortic lymphadenectomy is routinely recommended to treat paratesticular rhabdomyosarcoma (RMS) because of the high incidence of lymph node involvement. ...Results obtained in this series demonstrate the ineffectiveness of systematic paraaortic lymphadenectomy in …
Paraaortic lymphadenectomy is routinely recommended to treat paratesticular rhabdomyosarcoma (RMS) because of the high inciden …
Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology.
Stewart RJ, Martelli H, Oberlin O, Rey A, Bouvet N, Spicer RD, Godzinski J, Stevens MC; International Society of Pediatric Oncology. Stewart RJ, et al. J Clin Oncol. 2003 Mar 1;21(5):793-8. doi: 10.1200/JCO.2003.06.040. J Clin Oncol. 2003. PMID: 12610176
PURPOSE: To report the results of the Malignant Mesenchymal Tumors studies (MMT 84 and 89) of the International Society of Pediatric Oncology (SIOP) in males with nonmetastatic paratesticular rhabdomyosarcoma. PATIENTS AND METHODS: From 1984 to 1994, 96 males were t …
PURPOSE: To report the results of the Malignant Mesenchymal Tumors studies (MMT 84 and 89) of the International Society of Pediatric Oncolog …
The role of surgical resection when combined with chemotherapy and radiation in the management of pelvic rhabdomyosarcoma.
Fleming ID, Etcubanas E, Patterson R, Rao B, Pratt C, Hustu O, Kumar M. Fleming ID, et al. Ann Surg. 1984 May;199(5):509-14. doi: 10.1097/00000658-198405000-00003. Ann Surg. 1984. PMID: 6721601 Free PMC article.
With the development of combined chemotherapy and radiation therapy for embryonal rhabdomyosarcoma, the role and extent of surgical resection of these pelvic tumors need to be defined. ...Fourteen children presented with paratesticular rhabdomyosarcoma …
With the development of combined chemotherapy and radiation therapy for embryonal rhabdomyosarcoma, the role and extent of sur …
Outcome, Treatment, and Treatment Failures in Patients Suffering Localized Embryonal Paratesticular Rhabdomyosarcoma: Results From the "Cooperative Weichteilsarkom Studiengruppe" Trials CWS-86, -91, -96, and -2002P.
Seitz G, Fuchs J, Martus P, Klingebiel T, Leuschner I, Schuck A, Dantonello TM, Koscielniak E; Cooperative Weichteilsarkom Studiengruppe (CWS).. Seitz G, et al. Ann Surg. 2016 Dec;264(6):1148-1155. doi: 10.1097/SLA.0000000000001550. Ann Surg. 2016. PMID: 27828824
OBJECTIVE: To evaluate outcome in respect to local treatment strategies in 4 prospective CWS trials in patients with paratesticular rhabdomyosarcoma (PTRMS). SUMMARY BACKGROUND DATA: PTRMS patients have a high number of surgical treatment failures. ...Secondary retr …
OBJECTIVE: To evaluate outcome in respect to local treatment strategies in 4 prospective CWS trials in patients with paratesticular …
Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma?
Wiener ES, Anderson JR, Ojimba JI, Lobe TE, Paidas C, Andrassy RJ, Raney RB, Qualman SJ, Donaldson SS, Maurer HM, Link MP, Crist WM, Grier HE. Wiener ES, et al. Semin Pediatr Surg. 2001 Aug;10(3):146-52. doi: 10.1053/spsu.2001.24695. Semin Pediatr Surg. 2001. PMID: 11481652
PURPOSE: Use of retroperitoneal lymph node dissection (RPLND) in paratesticular rhabdomyosarcoma (PTRMS) is controversial and has changed over the past 2 decades. The Intergroup Rhabdomyosarcoma Study Group (IRSG) required ipsilateral RPLND (IRPLND) for all p …
PURPOSE: Use of retroperitoneal lymph node dissection (RPLND) in paratesticular rhabdomyosarcoma (PTRMS) is controversial and …
Current concepts in the management of paratesticular rhabdomyosarcoma.
Debruyne FM, Bökkerink JP, de Vries JD. Debruyne FM, et al. Eur Urol. 1985;11(5):289-93. doi: 10.1159/000472521. Eur Urol. 1985. PMID: 4076265
Paratesticular rhabdomyosarcoma is a rare malignant disease most commonly seen in infants and children. ...On hand of 7 of our own patients, uniformly treated at one institution, a review of the current approach of paratesticular rhabdomyosarcomas with excell …
Paratesticular rhabdomyosarcoma is a rare malignant disease most commonly seen in infants and children. ...On hand of 7 of our …
The management of paratesticular rhabdomyosarcoma.
Hamilton CR, Pinkerton R, Horwich A. Hamilton CR, et al. Clin Radiol. 1989 May;40(3):314-7. doi: 10.1016/s0009-9260(89)80222-3. Clin Radiol. 1989. PMID: 2752691
Between 1974 and 1986 15 patients presented to the Royal Marsden Hospital with paratesticular rhabdomysarcoma. Of 10 patients presenting with Stage I disease, eight were treated with adjuvant chemotherapy. ...
Between 1974 and 1986 15 patients presented to the Royal Marsden Hospital with paratesticular rhabdomysarcoma. Of 10 patients present …
11 results